SCHEMBL7741266

SCHEMBL7741266

O=C1Nc2ncccc2/C1=N\OC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TNKS2 Q9H2K2 10/20 0.41
MAPT P10636 3/20 0.36
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
MCL1 Q07820 1/20 0.36
APP P05067 2/20 0.36
SNCA P37840 2/20 0.36
CTRC Q99895 1/20 0.36
RAF1 P04049 1/20 0.36
NTRK1 P04629 1/20 0.36
IDO1 P14902 1/20 0.33
LRRK2 Q5S007 1/20 0.33
ALOX15 P16050 1/20 0.32
MAPK10 P53779 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7745717 0.79 LRRK2 (0.54) MAPTALDH1A1NPC1GAARAB9A
SCHEMBL6669676 0.75 LRRK2 (0.38) CYP1A2MAPTALDH1A1NPC1GAA
SCHEMBL6669681 0.75 LRRK2 (0.38) CYP1A2MAPTALDH1A1NPC1GAA
SCHEMBL21994233 0.72 CYP1A2 (0.51) CYP1A2SMN1; SMN2TNKS2MAPTALDH1A1
SCHEMBL6246169 0.72 ALDH1A1 (0.43) CYP1A2SMN1; SMN2TNKS2MAPTALDH1A1
SCHEMBL6246167 0.72 ALDH1A1 (0.43) CYP1A2SMN1; SMN2TNKS2MAPTALDH1A1
SCHEMBL29759335 0.66 CYP1A2 (0.59) CYP1A2SMN1; SMN2TNKS2MAPTALDH1A1
SCHEMBL22806019 0.66 CYP1A2 (0.59) CYP1A2SMN1; SMN2TNKS2MAPTALDH1A1
SCHEMBL2493976 0.66 CYP1A2 (0.59) CYP1A2SMN1; SMN2TNKS2MAPTALDH1A1
SCHEMBL20218242 0.66 CYP1A2 (0.59) CYP1A2SMN1; SMN2TNKS2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed